Author:
Richards Georgia C,Aronson Jeffrey K,Heneghan Carl,Mahtani Kamal R,Koshiaris Constantinos,Persaud Nav
Abstract
IntroductionOpioids are deemed essential medicines by the World Health Organization (WHO). However, many countries have inadequate access to them. Whether including opioids in national essential medicines lists (EMLs) influences national opioid consumption has not been evaluated.MethodsWe conducted a cross-sectional study to determine whether the listing of opioids in national EMLs was associated with consumption. We quantified the numbers and types of all opioids included in 137 national EMLs, for comparison with opioids in the WHO’s Model List of Essential Medicines. Using the International Narcotics Control Board (INCB) consumption statistics for 2015–2017, we assessed the relation between annual mean opioid consumption (mg/person) and the numbers of opioids included in EMLs, controlling for region, population, healthcare expenditure, life expectancy, gross domestic product, human development and corruption.ResultsFive opioids were included in the 20th edition of the WHO’s Model List of Essential Medicines: codeine, fentanyl, loperamide, methadone and morphine. On average, countries’ lists included significantly (p<0.05) more opioids than the WHO’s Model List. However, there were wide variations in the numbers (median 6 opioids; IQR: 5–9) and types (n=33) of opioids included in national EMLs. Morphine (95%), fentanyl (83%) and codeine (69%) were the most commonly included opioids. Most national EMLs were out of date (median publication date: 2011, IQR: 2009–2013). After adjusting for country characteristics, there was no relation between mean opioid consumption and the number of opioids in EMLs.ConclusionsIncluding opioids in national EMLs was not associated with consumption. National EMLs should be regularly updated to reflect the availability of opioids and the populations’ needs for managing pain.
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference26 articles.
1. WHO . 20Th essential medicines list, 2017. Available: https://www.who.int/medicines/news/2017/20th_essential_med-list/en/ LB - HW7p
2. WHO Expert Committee on the Selection of Essential Drugs & World Health Organization . The selection of essential drugs : report of a WHO expert committee [meeting held in Geneva from 17 to 21 October 1977], 1977. Available: https://apps.who.int/iris/handle/10665/41272
3. Essential medicines and the challenges in the Evidence-Based Manifesto
4. Who essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys;Holloway;PLoS Med,2014
5. Comparison of essential medicines Lists in 137 countries;Persaud;Bull World Health Organ,2019
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献